作者: Debra L. Friedman , Wendy Leisenring , Jeffrey L. Schwartz , H. Joachim Deeg
DOI: 10.1532/IJH97.03178
关键词:
摘要: Hematopoietic stem cell transplantation is being successfully used to treat a variety of malignant and nonmalignant disorders. This therapy has resulted in an increasing number survivors who are at risk for adverse long-term outcomes, including the development second subsequent neoplasms.We review incidence spectrum posttransplantation malignancies discuss factors future directions research.